國立虎尾科技大學 |

Investigation of NADPH Oxidase as a Link Between Vascular and Metabolic Dysfunction.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Investigation of NADPH Oxidase as a Link Between Vascular and Metabolic Dysfunction./
作者:	Meza, Cesar Arturo.
面頁冊數:	1 online resource (88 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-04, Section: B.
Contained By:	Dissertations Abstracts International85-04B.
標題:	Physiology. -
電子資源:	click for full text (PQDT)
ISBN:	9798380413343

Investigation of NADPH Oxidase as a Link Between Vascular and Metabolic Dysfunction.
Meza, Cesar Arturo.

Investigation of NADPH Oxidase as a Link Between Vascular and Metabolic Dysfunction. - 1 online resource (88 pages)

Source: Dissertations Abstracts International, Volume: 85-04, Section: B.

Thesis (Ph.D.)--The Florida State University, 2023.

Includes bibliographical references

INTRODUCTION: Obesity is associated with increased cardiometabolic disease risk, although the vascular and metabolic features of obesity are often studied independently. Resistance to both insulin-mediated suppression of lipolysis and increases in microvascular blood flow are important risk factors for cardiometabolic diseases. Emerging evidence points to heightened NADPH oxidase (Nox) activity as a critical feature of reduced vascular and metabolic function. Overproduction of Nox-derived reactive oxygen species (ROS) is a major source of microvascular dysfunction in obesity and increased adipose tissue Nox activity is a main determinant of insulin resistance. In addition, Nox-derived ROS is an important component of increased lipolysis; however, the mechanisms by which Nox regulates lipolysis are unknown. In addition, the mechanistic basis for Nox in the intricate relationship between insulin control of vascular and metabolic responses is not well described. PURPOSE: The overall objective of this study was to investigate whether increased Nox-derived ROS production impairs blood glucose profiles by reducing insulin-mediated suppression of lipolysis. METHODS: Sixteen sedentary, non-obese, otherwise healthy males and females (males = 1, females = 15; age: 21.7 ± 5 years; body mass index: 22.7 ± 4 kg/m2 ) participated in this study. Participants completed three study visits, each after a ten-hour overnight fast. During the first study visit, anthropometric assessments were completed, as well as measurement of fasting blood glucose and blood pressure. During the second study visit, assessments of body composition (via dual-energy x-ray absorptiometry, DXA) and maximal aerobic capacity (VO2peak) were completed. The final study visit was the main experimental visit, where participants underwent microdialysis and hyperinsulinemic-euglycemic procedures to monitor local adipose tissue (total and Nox-dependent) ROS production and lipolysis (measured as dialysate glycerol) under basal as well as hyperinsulinemic conditions. Total dialysate H2O2 concentrations, including dismutated superoxide, were detected via perfusion of Amplex UltraRed reagent, horseradish peroxidase and superoxide dismutase through microdialysis probes. Further, microdialysis probes were perfused with either isoproterenol (β-adrenergic agonist) or atrial natriuretic peptide (ANP) to stimulate lipolysis through independent signaling pathways, then additionally perfused with apocynin (Nox inhibitor) to determine the contributions of Nox to lipolysis. RESULTS: Upon perfusion of apocynin, the dialysate concentrations of H2O2 decreased in the control (without apocynin: 1.17 ± 0.5 µM, with apocynin: 0.66 ± 0.2 µM; p = 0.003) and isoproterenol probes (without apocynin: 1.09 ± 0.6 µM, with apocynin: 0.68 ± 0.3 µM; p = 0.03). Isoproterenol and ANP perfusion significantly increased dialysate glycerol concentrations compared to the control probe (control: 56.0 ± 21.9, isoproterenol: 125.6 ± 59.8, ANP: 130.9 ± 47.7 µmol/L; p < 0.0001). However, apocynin perfusion had no effect on dialysate glycerol concentrations in the control (p = 0.99), isoproterenol (p = 0.99) or ANP (p = 0.59) probes in the basal state. During the clamp, apocynin perfusion decreased dialysate H2O2 concentrations in control (without apocynin: 1.3 ± 0.6 µM, with apocynin: 0.79 ± 0.3 µM; p = 0.046), isoproterenol (without apocynin: 1.58 ± 0.8 µM, with apocynin: 0.83 ± 0.3 µM; p = 0.02) and ANP (without apocynin: 1.60 ± 0.60 µM, with apocynin: 0.95 ± 0.3 µM; p = 0.04) probes. Hyperinsulinemia decreased dialysate glycerol concentrations compared to the basal state (basal: 56.0 ± 21.9 µmol/L, clamp: 32.8 ± 20.2 µmol/L; p = 0.02). In addition, dialysate glycerol concentrations decreased in the isoproterenol probe following apocynin perfusion during the clamp procedure (without apocynin: 126.1 ± 38 µmol/L, with apocynin: 91.9 ± 25.7 µmol/L; p = 0.002). Further, there was a correlation between basal adipose tissue lipolytic rates and Nox contributions to basal adipose tissue lipolysis (r = - 0.66, p = 0.005), and individuals with lower insulin sensitivity (glucose disposal rate) tended to have high basal Nox-mediated ROS production (r = 0.56, p = 0.04). CONCLUSIONS: The novel findings of this study are that Nox is a stimulus of adipose tissue ROS production in healthy individuals, and this effect contributes to increases in adipose tissue lipolysis during hyperinsulinemic conditions. The mechanism by which Nox increases lipolysis involves β-adrenergic signaling and is independent of the ANP pathway. These data have important implications for individuals with insulin resistance and excess adiposity, as basal adipose tissue Nox activity was highest in individuals with lower insulin sensitivity and higher basal lipolytic rates, which may impair blood glucose regulation and vascular function. Overall, these study findings provide in vivo evidence of a novel regulator of adipose tissue lipolysis.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798380413343Subjects--Topical Terms:

673386
Physiology.
Subjects--Index Terms:

Adipose tissueIndex Terms--Genre/Form:

554714
Electronic books.

Investigation of NADPH Oxidase as a Link Between Vascular and Metabolic Dysfunction.
LDR:06445ntm a22004097 4500 001 1149340
005 20241015112519.5
006 m o d
007 cr bn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798380413343
035 $a (MiAaPQ)AAI30530487
035 $a AAI30530487
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Meza, Cesar Arturo. $3 1475531
245 1 0 $a Investigation of NADPH Oxidase as a Link Between Vascular and Metabolic Dysfunction.
264 0 $c 2023
300 $a 1 online resource (88 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-04, Section: B.
500 $a Advisor: Hickner, Robert C.
502 $a Thesis (Ph.D.)--The Florida State University, 2023.
504 $a Includes bibliographical references
520 $a INTRODUCTION: Obesity is associated with increased cardiometabolic disease risk, although the vascular and metabolic features of obesity are often studied independently. Resistance to both insulin-mediated suppression of lipolysis and increases in microvascular blood flow are important risk factors for cardiometabolic diseases. Emerging evidence points to heightened NADPH oxidase (Nox) activity as a critical feature of reduced vascular and metabolic function. Overproduction of Nox-derived reactive oxygen species (ROS) is a major source of microvascular dysfunction in obesity and increased adipose tissue Nox activity is a main determinant of insulin resistance. In addition, Nox-derived ROS is an important component of increased lipolysis; however, the mechanisms by which Nox regulates lipolysis are unknown. In addition, the mechanistic basis for Nox in the intricate relationship between insulin control of vascular and metabolic responses is not well described. PURPOSE: The overall objective of this study was to investigate whether increased Nox-derived ROS production impairs blood glucose profiles by reducing insulin-mediated suppression of lipolysis. METHODS: Sixteen sedentary, non-obese, otherwise healthy males and females (males = 1, females = 15; age: 21.7 ± 5 years; body mass index: 22.7 ± 4 kg/m2 ) participated in this study. Participants completed three study visits, each after a ten-hour overnight fast. During the first study visit, anthropometric assessments were completed, as well as measurement of fasting blood glucose and blood pressure. During the second study visit, assessments of body composition (via dual-energy x-ray absorptiometry, DXA) and maximal aerobic capacity (VO2peak) were completed. The final study visit was the main experimental visit, where participants underwent microdialysis and hyperinsulinemic-euglycemic procedures to monitor local adipose tissue (total and Nox-dependent) ROS production and lipolysis (measured as dialysate glycerol) under basal as well as hyperinsulinemic conditions. Total dialysate H2O2 concentrations, including dismutated superoxide, were detected via perfusion of Amplex UltraRed reagent, horseradish peroxidase and superoxide dismutase through microdialysis probes. Further, microdialysis probes were perfused with either isoproterenol (β-adrenergic agonist) or atrial natriuretic peptide (ANP) to stimulate lipolysis through independent signaling pathways, then additionally perfused with apocynin (Nox inhibitor) to determine the contributions of Nox to lipolysis. RESULTS: Upon perfusion of apocynin, the dialysate concentrations of H2O2 decreased in the control (without apocynin: 1.17 ± 0.5 µM, with apocynin: 0.66 ± 0.2 µM; p = 0.003) and isoproterenol probes (without apocynin: 1.09 ± 0.6 µM, with apocynin: 0.68 ± 0.3 µM; p = 0.03). Isoproterenol and ANP perfusion significantly increased dialysate glycerol concentrations compared to the control probe (control: 56.0 ± 21.9, isoproterenol: 125.6 ± 59.8, ANP: 130.9 ± 47.7 µmol/L; p < 0.0001). However, apocynin perfusion had no effect on dialysate glycerol concentrations in the control (p = 0.99), isoproterenol (p = 0.99) or ANP (p = 0.59) probes in the basal state. During the clamp, apocynin perfusion decreased dialysate H2O2 concentrations in control (without apocynin: 1.3 ± 0.6 µM, with apocynin: 0.79 ± 0.3 µM; p = 0.046), isoproterenol (without apocynin: 1.58 ± 0.8 µM, with apocynin: 0.83 ± 0.3 µM; p = 0.02) and ANP (without apocynin: 1.60 ± 0.60 µM, with apocynin: 0.95 ± 0.3 µM; p = 0.04) probes. Hyperinsulinemia decreased dialysate glycerol concentrations compared to the basal state (basal: 56.0 ± 21.9 µmol/L, clamp: 32.8 ± 20.2 µmol/L; p = 0.02). In addition, dialysate glycerol concentrations decreased in the isoproterenol probe following apocynin perfusion during the clamp procedure (without apocynin: 126.1 ± 38 µmol/L, with apocynin: 91.9 ± 25.7 µmol/L; p = 0.002). Further, there was a correlation between basal adipose tissue lipolytic rates and Nox contributions to basal adipose tissue lipolysis (r = - 0.66, p = 0.005), and individuals with lower insulin sensitivity (glucose disposal rate) tended to have high basal Nox-mediated ROS production (r = 0.56, p = 0.04). CONCLUSIONS: The novel findings of this study are that Nox is a stimulus of adipose tissue ROS production in healthy individuals, and this effect contributes to increases in adipose tissue lipolysis during hyperinsulinemic conditions. The mechanism by which Nox increases lipolysis involves β-adrenergic signaling and is independent of the ANP pathway. These data have important implications for individuals with insulin resistance and excess adiposity, as basal adipose tissue Nox activity was highest in individuals with lower insulin sensitivity and higher basal lipolytic rates, which may impair blood glucose regulation and vascular function. Overall, these study findings provide in vivo evidence of a novel regulator of adipose tissue lipolysis.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Physiology. $3 673386
650 4 $a Endocrinology. $3 645497
650 4 $a Health sciences. $3 1179212
650 4 $a Biomedical engineering. $3 588770
653 $a Adipose tissue
653 $a Endothelium
653 $a Insulin resistance
653 $a Lipolysis
653 $a Reactive oxygen species
655 7 $a Electronic books. $2 local $3 554714
690 $a 0719
690 $a 0409
690 $a 0566
690 $a 0541
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a The Florida State University. $b Nutrition, Food & Exercise Science. $3 1472235
773 0 $t Dissertations Abstracts International $g 85-04B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30530487 $z click for full text (PQDT)